Trials / Completed
CompletedNCT01342315
Topical Antifungal Treatment for Tinea Cruris
A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Cruris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 483 (actual)
- Sponsor
- Medicis Global Service Corporation · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 33525 | Daily dosing |
| DRUG | Placebo | Daily dosing |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-03-01
- Completion
- 2012-05-01
- First posted
- 2011-04-27
- Last updated
- 2013-08-28
Locations
21 sites across 5 countries: United States, Belize, El Salvador, Honduras, Puerto Rico
Source: ClinicalTrials.gov record NCT01342315. Inclusion in this directory is not an endorsement.